News search
|
About the CNIC 19 Mar 2026 |
|
Research 26 Feb 2026 The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines |
|
Research 16 Feb 2026 A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail. |
|
Research 10 Feb 2026 The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia |
|
Research 5 Feb 2026 A prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction. |
|
Research 2 Feb 2026 A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves |
|
Research 28 Jan 2026 A study published in Immunity reveals that type I interferons (IFN‑I) help resolve inflammation by inducing changes in macrophage mitochondria |
|
Research 14 Jan 2026 A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered. |
- 1 of 34
- next ›
















